The World Orphan Drug Congress Europe returns to Amsterdam from 26–28 October 2026, bringing together the global rare disease and orphan drug community for three days of collaboration, innovation and knowledge sharing.
Recognised as one of the world’s leading rare disease conferences, the event welcomes patient organisations, researchers, clinicians, regulators, policymakers, pharmaceutical and biotech companies, investors and industry leaders. The programme covers the full orphan drug development pathway, including cell and gene therapies, genetic testing, clinical trials, market access, regulatory affairs, real-world evidence and patient engagement.
Pre-congress workshops take place on 26 October, followed by the main congress on 27–28 October at the RAI Congress Centre, Amsterdam. The event provides valuable opportunities to learn about the latest advances in rare disease research, connect with international experts and explore innovative approaches to improving diagnosis, treatment and access to therapies.
Location: RAI Congress Centre, Amsterdam, Netherlands
Dates: 26–28 October 2026
Format: In-person
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are as essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
The World Orphan Drug Congress Europe returns to Amsterdam from 26–28 October 2026, bringing together the global rare disease and orphan drug community for three days of collaboration, innovation and knowledge sharing.
Recognised as one of the world’s leading rare disease conferences, the event welcomes patient organisations, researchers, clinicians, regulators, policymakers, pharmaceutical and biotech companies, investors and industry leaders. The programme covers the full orphan drug development pathway, including cell and gene therapies, genetic testing, clinical trials, market access, regulatory affairs, real-world evidence and patient engagement.
Pre-congress workshops take place on 26 October, followed by the main congress on 27–28 October at the RAI Congress Centre, Amsterdam. The event provides valuable opportunities to learn about the latest advances in rare disease research, connect with international experts and explore innovative approaches to improving diagnosis, treatment and access to therapies.
Location: RAI Congress Centre, Amsterdam, Netherlands
Dates: 26–28 October 2026
Format: In-person
Details
Organiser
Venue